Company profile
DarioHealth Corp.
NASDAQ: DRIO · Healthcare · Medical - Specialties
#534 of 1,418 Healthcare companies by revenue29th-percentile growth
EA Score
49DFH 45DQ 60GM 35SS 59
v0.1 · 65/100 weight · provisional
↑ disclosure history, workforce scale · ↓ revenue growth (YoY), 3-yr revenue growth
Methodology →Revenue TTM
$21.2M
Rev growth YoY (TTM)
-24.4%
Net income (FY)
-$41.7M
Employees
163
as of 2026-08-19
Market cap
$52.5M
as of 2026-08-19
Financials — latest annual
SEC EDGAR · USD-normalizedConceptUSDNativeFY
Revenue$22.4M$22.4M2025
Net income-$41.7M-$41.7M2025
Operating income-$36.7M-$36.7M2025
Total assets$110.1M$110.1M2025
Equity$67.9M$67.9M2025
Revenue trend
FY2019 – FY2025 · USD
FY19
FY19
FY20
FY21
FY22
FY23
FY24
FY25
Revenue by segment
Filed disclosures · FY2025
By product
Service100%
By geography
Not disclosed.
The read
What is DarioHealth Corp.’s revenue?
DarioHealth Corp. booked $22.4M in FY2025 revenue, contracting 17% year over year — slower than 71% of Healthcare companies we track, at a -186.6% net margin.
Peers · Healthcare
Wellgistics Health, Inc.19DBody and Mind Inc.——NextCure, Inc.38DAyurcann Holdings Corp.57CItem 9 Labs Corp.——SQZ Biotechnologies Company——Neighbors
New York →Key facts
CEOErez Raphael
SectorHealthcare
IndustryMedical - Specialties
HeadquartersNew York City, NY
ExchangeNASDAQ: DRIO
Employees163
IPO date2016-03-14
Financials: SEC EDGAR (XBRL), USD-normalized per IAS 21 · TTM/quarterly + segments: FMP from filed disclosures · Filings: EDGAR submissions. County headcount and EA Score are in progress — see docs/DATA_GAPS.md.